Literature DB >> 10882063

A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE.

C Brou1, F Logeat, N Gupta, C Bessia, O LeBail, J R Doedens, A Cumano, P Roux, R A Black, A Israël.   

Abstract

The Notch1 receptor is presented at the cell membrane as a heterodimer after constitutive processing by a furin-like convertase. Ligand binding induces the proteolytic release of Notch intracellular domain by a gamma-secretase-like activity. This domain translocates to the nucleus and interacts with the DNA-binding protein CSL, resulting in transcriptional activation of target genes. Here we show that an additional processing event occurs in the extracellular part of the receptor, preceding cleavage by the gamma-secretase-like activity. Purification of the activity accounting for this cleavage in vitro shows that it is due to TACE (TNFalpha-converting enzyme), a member of the ADAM (a disintegrin and metalloprotease domain) family of metalloproteases. Furthermore, experiments carried out on TACE-/- bone marrow-derived monocytic precursor cells suggest that this metalloprotease plays a prominent role in the activation of the Notch pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882063     DOI: 10.1016/s1097-2765(00)80417-7

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  361 in total

1.  In search of gamma-secretase: presenilin at the cutting edge.

Authors:  D J Selkoe; M S Wolfe
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 2.  T-cell regulation of peripheral tolerance and immunity: the potential role for Notch signalling.

Authors:  G F Hoyne; M J Dallman; J R Lamb
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

3.  A physiologic signaling role for the gamma -secretase-derived intracellular fragment of APP.

Authors:  Malcolm A Leissring; M Paul Murphy; Tonya R Mead; Yama Akbari; Michael C Sugarman; Mehrdad Jannatipour; Brigitte Anliker; Ulrike Müller; Paul Saftig; Bart De Strooper; Michael S Wolfe; Todd E Golde; Frank M LaFerla
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

4.  Notch receptor cleavage depends on but is not directly executed by presenilins.

Authors:  Yoshihito Taniguchi; Helena Karlström; Johan Lundkvist; Tomohiko Mizutani; Akira Otaka; Monica Vestling; Alan Bernstein; Dorit Donoviel; Urban Lendahl; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

5.  Nrarp is a novel intracellular component of the Notch signaling pathway.

Authors:  E Lamar; G Deblandre; D Wettstein; V Gawantka; N Pollet; C Niehrs; C Kintner
Journal:  Genes Dev       Date:  2001-08-01       Impact factor: 11.361

6.  The notch intracellular domain can function as a coactivator for LEF-1.

Authors:  D A Ross; T Kadesch
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

7.  SHARP is a novel component of the Notch/RBP-Jkappa signalling pathway.

Authors:  Franz Oswald; Ulrike Kostezka; Kathy Astrahantseff; Soizic Bourteele; Karin Dillinger; Ulrich Zechner; Leopold Ludwig; Monika Wilda; Horst Hameister; Walter Knöchel; Susanne Liptay; Roland M Schmid
Journal:  EMBO J       Date:  2002-10-15       Impact factor: 11.598

8.  TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity.

Authors:  Ganesan Ramesh; W Brian Reeves
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

9.  Heparan sulfate-modulated, metalloprotease-mediated sonic hedgehog release from producing cells.

Authors:  Tabea Dierker; Rita Dreier; Arnd Petersen; Christian Bordych; Kay Grobe
Journal:  J Biol Chem       Date:  2009-01-27       Impact factor: 5.157

10.  Fringe glycosyltransferases differentially modulate Notch1 proteolysis induced by Delta1 and Jagged1.

Authors:  Liang-Tung Yang; James T Nichols; Christine Yao; Jennifer O Manilay; Ellen A Robey; Gerry Weinmaster
Journal:  Mol Biol Cell       Date:  2004-12-01       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.